Smiths Falls-based Canopy Growth will study the effects on cannabinoids on patients facing complications from concussions thanks to a new partnership with the NHL Alumni Association and Neeka Health Canada.
If successful, the partners hope the research could unlock new avenues to use cannabinoids in post-concussion treatment for athletes and everyday patients.
The local pot producer announced over the weekend it will work with its partners to determine how effective cannabis can be in addressing common post-concussion complications, such as depression, dementia or chronic traumatic encephalopathy (CTE).
(Sponsored)
Invest with confidence: Hydro Ottawa funds technical studies for business retrofits
For Ottawa businesses, the opportunity to improve building performance has never been greater. Energy retrofits can cut emissions, strengthen operations, extend the life of assets, reduce operating costs, and position
Family-owned Coke Canada Bottling investing to grow in Ottawa-Gatineau
Have you ever wondered where your favourite Coca-Cola products come from? Few people in know that over 300 popular beverages products, like Coca-Cola, Coke Zero, Fuze, Fanta, Monster Energy, A&W
The research will look to improve cognitive functions for the estimated 1.6 million to 3.8 million athletes that suffer concussions annually, 10 to 15 per cent of whom go on to develop symptoms of mental degradation. About 100 former NHL players will participate in the study.
Trials will begin this summer and are expected to last one year.
